Abstract
Diabetes and its complications are systemic metabolic disorders triggered by chronic hyperglycemia, with the NOD‑like receptor family pyrin domain‑containing 3 (NLRP3) inflammasome carrying out a central role in disease progression. Activation of the NLRP3 inflammasome is involved not only in the onset of diabetes but also in its complications, including cardiovascular disease, nephropathy and retinopathy. The present review outlines the core mechanisms of the NLRP3 inflammasome and its specific contributions to diabetes and associated conditions. Additionally, emerging therapeutic strategies that target the NLRP3 inflammasome were explored, offering novel insights into the management of diabetes and its associated complications.